Efficacy and Safety of Lanreotide Versus Placebo for Treatment of Patients With Digestive Fistulae

Update Il y a 4 ans
Reference: NCT00729313

Woman and Man

Extract

The purpose of the protocol, is to determine whether lanreotide 30 mg is effective in the treatment of patients with digestive fistulae.


Inclusion criteria

  • Digestive Fistulae

Links